APAF1 and ovarian carcinoma: This transfer ultimately conferred paclitaxel chemoresistance properties to the recipient ovarian carcinoma cells due to the direct regulatory effect of miR-21-5p on the transcript for apoptotic protease activating factor 1 (APAF1) [205].